A new chiral monooxoruthenium(IV) complex containing 2,6-bis[(4S, 7R)-7,8,8-trimethyl-4,5,6,7-tetrahydro-4,7-methanoindazol-2-yl]pyridine and 2,2′-bipyridine ligands is prepared and the X-ray crystal structure of its RuII–OH2 precusor determined; this RuIVO complex catalyses epoxidation of Unfunctionalized alkenes with promising enantioselectivity.
No takes yet. Share an insight, caveat, or question.
Fung et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: